Tabimorelin is a growth hormone releasing factor agonist potentially for the treatment of growth hormone deficit. Tabimorelin is a drug which acts as a potent, orally -active agonist of the ghrelin/growth hormone secretagogue receptor (GHSR) and growth hormone secretagogue, mimicking the effects of the endogenous peptide agonist ghrelin as a stimulator of growth hormone (GH) release. References: Shimatsu A. [Ghrelin-related drugs: clinical perspectives]. Nihon Rinsho. 2004 Sep;62 Suppl 9:435-8. Review. Japanese. PubMed PMID: 15506422.

纯度：≥98%

CAS：193079-69-5